Back
Sage Therapeutics Stock Predictions
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
22
SAGE
Sage Therapeutics
Last Price:
5.94
Seasonality Move:
19.95%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!Sage Therapeutics Stock Forecast
- Over the next 52 weeks, Sage Therapeutics has on average historically fallen by 3.5% based on the past 10 years of stock performance.
- Sage Therapeutics has fallen lower in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Sage Therapeutics Stock Undervalued?
The current Sage Therapeutics [SAGE] share price is $5.94. The Score for SAGE is 22, which is 56% below its historic median score of 50, and infers higher risk than normal. - SAGE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Sage Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Sage Therapeutics has on average historically fallen by 3.5% based on the past 10 years of stock performance.
Sage Therapeutics Stock Rating
Sell
22
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics overpriced?
- Sage Therapeutics has fallen lower in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Sage Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sagerx.com
52-Week Data
52-Week High:
28.26
52-Week Low:
5.64
Prediction Charts
Market Cap:
363.37M
Price in USD:
5.94
Volume:
575.18K
Beta:
1.36
Technical Analysis
SMA50:
7.31
SMA100:
8.83
SMA200:
13.26
52-Wk Change:
-72.1%
Stock Predictions
-
Is Sage Therapeutics stock public?
Yes, Sage Therapeutics is a publicly traded company. -
What is the Sage Therapeutics stock quote today?
The Sage Therapeutics stock price is 5.94 USD today. -
How to buy Sage Therapeutics stock online?
You can buy Sage Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-16 | 6.91 | 7.27 | 7.30 | 6.91 |
| Oct-18 | 7.23 | 7.57 | 7.57 | 7.15 |
| Oct-21 | 7.55 | 7.79 | 7.81 | 7.41 |
| Oct-22 | 7.80 | 7.65 | 7.83 | 7.45 |
| Oct-23 | 7.59 | 7.65 | 7.72 | 7.33 |
| Oct-24 | 7.68 | 7.85 | 7.95 | 7.57 |
| Oct-25 | 7.89 | 8.01 | 8.16 | 7.84 |
| Oct-28 | 8.10 | 8.54 | 8.62 | 8.10 |
| Oct-29 | 8.53 | 8.49 | 8.70 | 8.34 |
| Oct-30 | 7.69 | 6.46 | 7.97 | 6.20 |
| Oct-31 | 6.39 | 6.09 | 6.59 | 5.92 |
| Nov-1 | 6.09 | 6.05 | 6.16 | 5.84 |
| Nov-4 | 5.92 | 5.81 | 6.12 | 5.80 |
| Nov-5 | 5.67 | 5.94 | 5.95 | 5.64 |
Sage Therapeutics Earnings
Sage Therapeutics Earnings Report: Per Share Sage Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Sage Therapeutics Forecast Revenue Growth
Sage Therapeutics Stock Analysis: Historical quarterly revenues per share for Sage Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.43 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.15 per share, and an increase next year of $2.10 per share.
* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.